Skip to content

The effect and neural changes underlying mindfulness meditation training in patients with comorbid internet gaming disorder and depression: A randomized clinical trial.

Xuefeng Xu, Huabin Wang, Shaoyu Cui, Chang Liu, Xiaolan Song, Guang-Heng Dong

Translational Psychiatry February 18, 2026 DOI: 10.1038/s41398-026-03837-6 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 70
Population Patients with internet gaming disorder and depression
Interventions Mindfulness meditation Progressive muscle relaxation
Duration 1-month study, 8 training sessions
Topics Depression Meditation
Key findings Mindfulness meditation reduced depression, addiction, and cravings more than progressive muscle relaxation in patients with IGD-D, and altered functional connectivity in brain networks linked to control and emotion regulation.

Abstract

Internet gaming disorder (IGD) has been recognized as a serious mental illness and is often accompanied by depression (IGD-D). An ideal treatment strategy should have effects on both the conditions. Mindfulness meditation (MM) has attracted substantial attention for the treatment of psychiatric diseases; however, its effects on IGD-D and the underlying mechanisms remain unknown. A total of 70 patients with IGD-D were randomly divided into the MM and progressive muscle relaxation (PMR) groups. Of these patients, 61 completed the 1-month study (MM group, n = 34; PMR group, n = 27), including pre- and post-resting-state functional magnetic resonance imaging (fMRI) and 8 training sessions. Regional homogeneity and degree centrality were calculated, and overlapping brain regions were selected as seed points for functional connectivity (FC) analysis. The correlation of FC with behavioral data and neurotransmitters was subsequently evaluated. Compared with the PMR group, the MM group had less severe depression, addiction, and cravings. FC analysis showed that MM increased FC in the executive control, frontal-striatal, and default mode networks. FC was significantly correlated with 5-Hydroxytryptamine 1 A receptor, serotonin transporter, vesicular acetylcholine transporter and dopamine receptors D1 and D2. This study demonstrated that MM was effective in the treatment of IGD-D. MM altered the default mode network, enhanced top-down control, and emotion regulation, and disrupted negative reinforcement mechanisms. These phenomena were supported by the correlation between FC and behavioral as well as biochemical measures, suggesting that MM is a promising therapy for IGD-D.

Comparable studies

Other randomized controlled trials on depression, most cited first.

Study Year Design Participants
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Subjects with DSM-IV major depression (treatment resistant) 2006 Randomized, placebo-controlled, double-blind crossover study n = 18
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics